You are here

Novo Nordisk

Puma's FDA Decider And Semaglutide's Head-To-Head Battle

Puma's FDA Decider And Semaglutide's Head-To-Head Battle

Seeking Alpha

Puma Biotechnology

Flag link:

Novo Nordisk Warns of Possible Cracks in Insulin Devices

Novo Nordisk Warns of Possible Cracks in Insulin Devices

RAPS.org

Flag link:

Novo Nordisk touts late-stage trial data for Tresiba insulin injection

Novo Nordisk touts late-stage trial data for Tresiba insulin injection

Drug Delivery Business News

clinical trials

Flag link:

Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

Reuters

Flag link:

What we know from BIO2017

What we know from BIO2017

BioPharma Dive

Seattle Genetics

ImmunoCellular Therapeutics

Flag link:

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Medical Marketing and Media

Flag link:

FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza

FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza

Fierce Pharma

advisory panels

Flag link:

Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label

Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label

Fierce Pharma

Flag link:

ADA preview: 5 things to watch in diabetes

ADA preview: 5 things to watch in diabetes

BioPharma Dive

Boehringer Ingelheim

PCSK9 inhibitors

Amgen Regeneron

Flag link:

Why Novo Nordisk A/S (ADR) Jumped 10.6% In May

Why Novo Nordisk A/S (ADR) Jumped 10.6% In May

Motley Fool

Flag link:

Top 10 diabetes drugs by 2016 sales

Top 10 diabetes drugs by 2016 sales

Fierce Pharma

Flag link:

AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study

AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study

PR Web

Flag link:

Novo Nordisk seeks to include cardiovascular data in Tresiba insulin label

Novo Nordisk seeks to include cardiovascular data in Tresiba insulin label

Drug Delivery Business News

Flag link:

AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?

AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?

Fierce Pharma

Flag link:

Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1

Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1

Fierce Pharma

Flag link:

Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets

Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets

Fierce Pharma

Flag link:

Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep

Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep

Fierce Pharma

Flag link:

Novo Nordisk launches Xultophy diabetes therapy in U.S.

Novo Nordisk launches Xultophy diabetes therapy in U.S.

Mass Device

type 2 diabetes

insulin degludec

Flag link:

Novo Nordisk reaches whistleblower settlement in 'white-coat' sales scheme lawsuit

Novo Nordisk reaches whistleblower settlement in 'white-coat' sales scheme lawsuit

Fierce Pharma

whistleblower lawsuits

Flag link:

5 Big Drugmakers With Important Catalysts in May

5 Big Drugmakers With Important Catalysts in May

Motley Fool

nonacog beta pegol

Flag link: